针对EGFR阳性癌症的EGFR向基纳米颗粒的治疗效果
Kochurani K Johnson1,2, Pramod Koshy1, Chantal Kopecky3
1School of Materials Science and Engineering, Faculty of Science, UNSW Sydney, Sydney, NSW, Australia.
Journal of biomaterials applications
|April 20, 2025
概括
针对EGFR的纳米纤维通过提供治疗效果和使光检测成为可能,有效地对癌症进行成像和治疗. 这种纳米配方由于其血红相容性,对癌症治疗药物和体内应用有希望.
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术 纳米技术
- 在瘤学瘤学.
背景情况:
- 皮表皮生长因子受体 (EGFR) 在各种癌症中过度表达,使其成为癌症管理的目标.
- 针对EGFR的治疗方法为癌症治疗和诊断提供了有前途的方法.
- 纳米纤维具有内在的抗癌性质,可以被功能化用于有针对性的输送.
研究的目的:
- 为了评估FITC标记的EGF功能化纳米纤维的体外治疗性能.
- 评估这些纳米粒子在EGFR阳性癌症细胞系中的有效性.
- 为了确认纳米配方的双重成像和治疗能力.
主要方法:
- 使用了三个EGFR阳性的癌细胞系:MDA-MB-231,PANC-1和HeLa.
- 通过西方斑点分析确认了EGFR结合的特异性.
- 通过细胞活力测定和反应性氧物种 (ROS) 测量评估治疗活性.
- 通过对焦成像和血液溶解试验评估诊断潜力.
主要成果:
- 在受治疗的细胞中显示出显著的ROS升高,表明治疗潜力.
- 在治疗5分钟内确认成功的光成像检测纳米粒子.
- EGF功能化的纳米纤维显示出与EGFR阳性细胞的特异性结合.
- 血液溶解测定证实了出色的血液兼容性,表明适合体内使用.
结论:
- 标记FITC的EGF功能化纳米纤维对EGFR阳性癌症表现出有希望的体外治疗能力.
- 纳米配方有效地向癌细胞,通过ROS诱导细胞死亡,并允许光成像.
- 证明的血红相容性支持在癌症治疗中体内应用的潜力.
相关概念视频
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Mitogens and the Cell Cycle
6.3K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K


